Pam Belluck
User banner image
User avatar
  • Pam Belluck

Posts

What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDA

Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly...

FDA Makes Alzheimer’s Drug Leqembi Widely Accessible

The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high...

Wyoming Judge Temporarily Blocks State’s Ban on Abortion Pills

The law was to take effect on July 1. It is the only state law that specifically outlaws the most common abortion method in the...

F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risks

The agency is expected to decide this summer whether to allow the first nonprescription sales of an oral contraceptive in the United States.

F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risks

The agency is expected to decide this summer whether to allow the first nonprescription sales of an oral contraceptive in the United States.

F.D.A. Advisers Weigh Allowing First U.S. Over-the-Counter Birth Control Pill

The panel heard strong support from the company and many doctors but concern from F.D.A. scientists.

Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the Market

The suit by GenBioPro, the generic maker of mifepristone, is the latest strand in the intense legal battle over abortion pills.

Appeals Court Says Abortion Pill Can Remain Available but Imposes Temporary Restrictions

The judges blocked the drug from being sent to patients through the mail and rolled back other steps the government had taken to ease access.

What’s Going On With the Abortion Pill Rulings by Federal Judges?

One invalidated the F.D.A.’s approval of the abortion pill mifepristone. The other ordered the F.D.A. to do nothing to restrict the pill’s availability.

Texas Judge Invalidates FDA Approval of the Abortion Pill Mifepristone

The Texas judge’s ruling was quickly contradicted by another federal judge in Washington State who ordered the F.D.A. to keep mifepristone available.